Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Professional Societies Continue To Disagree On Carotid Stent Coverage

This article was originally published in The Gray Sheet

Executive Summary

Groups pushing for expanded Medicare coverage for carotid stenting are unhappy with a CMS proposal on the matter, and are hoping that interventionalists and surgeons can change the agency's mind by agreeing on which patients are good candidates for the procedure

You may also be interested in...



Rushed Judgment? CMS’ Status Quo Carotid Stenting Decision Comes Early

Physicians interested in expanding Medicare coverage for carotid stenting were taken by surprise last week when CMS issued a decision to maintain its current policies just one day before new data supporting the procedure were published

Rushed Judgment? CMS’ Status Quo Carotid Stenting Decision Comes Early

Physicians interested in expanding Medicare coverage for carotid stenting were taken by surprise last week when CMS issued a decision to maintain its current policies just one day before new data supporting the procedure were published

Carotid stenting status quo

In a 1July 31 draft decision memo, CMS proposes to keep its current national coverage policy for carotid stenting, which covers stenting with embolic protection at a CMS-approved facility in high-risk patients with symptomatic carotid artery stenosis greater than 70%. The agency says "currently published data is not sufficient to expand coverage beyond the currently covered patient populations" and that it "believes in the importance of completing the ongoing randomized clinical trials and encourages future RCTs with medical therapy comparator arms." In December, a group of professional societies asked CMS to extend coverage to patients at high risk due to defined anatomic factors, and who have either symptomatic carotid artery stenosis of 50% or greater or asymptomatic carotid artery stenosis of 80% or greater. In June, the request was amended to include the Society for Vascular Surgery's recommendation that CMS use national society registries to collect data on carotid stenting instead of the Medicare data submission system (2"The Gray Sheet" June 16, 2008, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel